Panel Discussion: The Lack of Robust Surrogate Biomarkers for Aging
Time: 11:30 am
day: Day One
Details:
Join keynote speakers as they discuss the lack of robust biomarkers in the longevity field and methods to overcome this including:
- Evaluating novel biomarkers that may correlate to registrable endpoints in longevity therapeutics
- Assessing how to move novel biomarkers towards regulatory approval
- Discussing the importance of developing defined biomarkers for aging and how we can use robust biomarkers to move the longevity field forward
